Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Roche Broadens Cervical Cancer Testing Lineup With MTM Acquisition

This article was originally published in The Gray Sheet

Executive Summary

Roche will seek PMA approval for MTM Laboratories’ cervical cancer tests following acquisition of the diagnostics firm for up to $270 million in a deal announced July 19.
Advertisement

Related Content

Ventana President Mara Aspinall: An Interview With “The Pink Sheet” DAILY
Medical Device and In Vitro Diagnostics/Research Deal Statistics Quarterly, Q3 2011
Roche Ramps Up Sales Force For U.S. Launch Of HPV Test
Roche Ramps Up Sales Force For U.S. Launch Of HPV Test
Advertisement
UsernamePublicRestriction

Register

MT030378

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel